InforCapital
CompanyDenmarkUpdated Apr 4, 2026
DARERL

DARERL

DARERL: Investor • focus on Venture Capital, Private Equity • active in Europe, Western Europe • offices in Denmark.

Company Profile

DARERL is an innovative firm specializing in the development of virtual human models, or digital twins, for the advancement of medical device and wearable technology. The company provides a scalable and cost-efficient alternative to traditional early-stage testing methods, such as phantoms, physical bench-testing, cadavers, and animal trials. Their platform offers highly detailed and validated 3D models of real human anatomies, enabling companies to conduct simulations and refine designs with precision and variability across diverse populations.

The firm's core offering is a groundbreaking SaaS platform that leverages precise digital anatomy to transform the development lifecycle of medical and wearable devices. This technology allows for interactive exploration of device interaction with virtual human models, customization of virtual populations, and large-scale simulation configurations for statistical analysis. DARERL's mission is to establish itself as the global standard for digital anatomy populations, thereby disrupting medical device and wearable development by significantly accelerating testing and validation processes.

Founded in 2024, DARERL is headquartered in Frederiksberg, Denmark. The company has attracted investment from notable entities such as BioInnovation Institute, Deep Tech Lab - Quantum, and Plug and Play Tech Center, indicating early recognition of its innovative approach and market potential. With a team of 9 employees, the firm is focused on supporting innovative applications from concept to clinical trials, including prototyping, design validation across large anatomical populations, and generating research evidence to support design decisions.

DARERL's expertise lies in creating high-resolution 3D models that replicate human anatomy down to the smallest detail, validated by clinical experts. This capability allows for faster development cycles, reduced costs, and enhanced precision in product design and performance validation, potentially cutting time to market for medical devices and wearables by 50-70%.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.